Specifically, it has been suggested that the expression of Tmc7 is enhanced at the onset of pancreatic cancer; therefore, it is expected to be a biomarker at the onset of pancreatic cancer [60]. This evidence concerns the gene TMC7 and familial pancreatic carcinoma.